Clinical Trial Update: Efficacy Study of Relaxation to 12 Weeks Against Placebo in the Overall Care Chronic Pain in Patients With Fibromyalgia [Phase 3]

View source ↗

Summary

Phase 3 efficacy study comparing a 12-week relaxation treatment to placebo for chronic pain in fibromyalgia; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED